Open AccessA one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
Author(s) -
Fen-Yu Ren,
Daxun Piao,
Xi-Xu Piao
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i31.4264
Subject(s) - entecavir , lamivudine , medicine , hbeag , gastroenterology , nucleoside analogue , hepatitis b , hepatitis b virus , serology , liver function , chronic hepatitis , refractory (planetary science) , nucleoside , immunology , virus , hbsag , biology , antibody , biochemistry , astrobiology
To evaluate the efficacy and safety of entecavir (ETV) in hepatitis Be antigen (HBeAg)-positive chronic hepatitis B (CHB) patients who had not received a nucleoside analogue and who had failed in lamivudine (LVD) therapy.